Ole Andreas Halvorsen, 10% Owner at BridgeBio Pharma, Inc. (BBIO), sold 3,500,000 shares at $44.00 ($154.0M) on 2025-06-27, disclosed to the SEC on 2025-07-01.
Open-market sale of $154.0M BBIO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2020-01-30 | $245.4M | — | Filing → |
| UROV | BUY | 2019-06-19 | $262K | — | Filing → |
| UROV | BUY | 2019-05-23 | $163K | — | Filing → |